Beam Therapeutics Inc. - stock earnings
BEAM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 142.8 million USD | 316.2 million USD |
| 2023Q3 | -96.1 million USD | 17.2 million USD |
| 2023Q2 | -82.8 million USD | 20.1 million USD |
| 2023Q1 | -84.0 million USD | 24.2 million USD |
| 2022Q4 | -38.3 million USD | 20.0 million USD |
| 2022Q3 | -109.6 million USD | 15.8 million USD |
| 2022Q2 | -48.5 million USD | 16.7 million USD |
| 2022Q1 | -55.2 million USD | 8.4 million USD |
| 2021Q4 | -64.6 million USD | 51.1 million USD |
| 2021Q3 | -28.1 million USD | 763000 USD |
| 2021Q2 | -76.3 million USD | 6000 USD |
| 2021Q1 | -201.6 million USD | 6000 USD |
| 2020Q4 | -95.5 million USD | 6000 USD |
| 2020Q3 | -34.5 million USD | 6000 USD |
| 2020Q2 | -34.2 million USD | 6000 USD |
| 2020Q1 | -30.5 million USD | 6000 USD |
| 2019Q4 | -27.9 million USD | 6000 USD |
| 2019Q3 | -19.0 million USD | 6000 USD |
| 2019Q2 | -17.9 million USD | 6000 USD |
| 2019Q1 | -13.6 million USD | ? USD |
| 2018Q4 | -25.2 million USD | ? USD |
| 2018Q3 | -69.8 million USD | ? USD |
BEAM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -132.5 million USD | 377.7 million USD |
| 2022 | -263.6 million USD | 60.9 million USD |
| 2021 | -341.4 million USD | 51.8 million USD |
| 2020 | -256.4 million USD | 24000 USD |
| 2019 | -78.4 million USD | 18000 USD |
| 2018 | -115.3 million USD | ? USD |
| 2017 | -8.0 million USD | ? USD |
BEAM
Price: $21.74
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.72 USD
P/E Ratio: -6.97
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 2.2 billion
Average Dividend Frequency: 4